Aegon Ltd. New York Registry Shares

Moat components are mixed. Intangible assets: Transamerica is a well-known U.S. brand with a large captive and affiliated distribution footprint including World Financial Group, which grew to over 95,000 licensed agents, supporting access to middle-market customers (moderate strength).

Switching costs: meaningful for in-force life, annuity, and workplace recordkeeping relationships due to underwriting, portability, and data migration hurdles, though not prohibitive for all product lines (moderate-to-strong). Network effects: limited, mainly at the agent/distributor level rather than at the customer platform level (weak).

Cost advantage: scale helps but Aegon is not the lowest-cost or largest U.S. life/retirement player (moderate). Efficient scale: some lines such as closed books and certain JV bancassurance niches benefit from natural market capacity constraints, but competition remains intense (moderate).

The moat is durable but not dominant and can erode if competitors out-execute in product, underwriting, or digital distribution; technology-driven direct models and fee compression in asset management are additional watchpoints.

Life and retirement pricing is largely competitive and regulated, limiting unilateral price increases. That said, management has obtained actuarially justified LTC premium increases and executed SGUL reinsurance to reduce capital employed and volatility, while expanding dynamic hedging of VA base contracts to cut market sensitivity.

These actions enhance economic value but are not the same as structural pricing power, and future approvals or reinsurance terms cannot be assumed. Overall margins should improve gradually from risk actions and mix, but latent pricing power is modest compared with regulated tollbooth-like franchises.

Aegon generated EUR 1.3 billion of operating capital generation in 2025 and EUR 829 million of free cash flow, meeting or exceeding targets.

Guidance implies around 5% free cash flow CAGR over 2026 to 2027, albeit with the UK contribution removed post-divestment and replaced over time by returns from the Standard Life stake and capital redeployment.

De-risking actions and strong capitalization support more stable remittances, yet earnings and capital generation remain exposed to interest rates, equity markets, lapse and mortality/morbidity assumptions, and regulatory changes. We judge medium predictability, improving as legacy exposures run down.

Group solvency stood at 184% at year-end 2025 and the U.S. RBC ratio at an estimated 424%, both above operating levels. Cash Capital at Holding was EUR 1.3 billion, within the group’s operating range, despite sizable 2025-2026 capital returns and an USD 0.8 billion capital injection to neutralize the SGUL transaction’s RBC impact.

Aegon’s operating subsidiaries hold solid external ratings (e.g., AM Best A for Transamerica), and the holding company is investment grade (S&P BBB+). Gross financial leverage declined to about EUR 4.85–4.9 billion by year-end 2025. These metrics indicate good resilience to shocks, though not at the very top of the sector.

Execution has been decisive. After monetizing the Netherlands franchise via the a.s.r. deal, Aegon agreed to sell Aegon UK for GBP 2.0 billion and is redeploying into deleveraging and buybacks.

In 2025 it returned EUR 1.1 billion to shareholders and proposed a 2025 total dividend of EUR 0.40 per share, while buybacks continued in 2026 with a EUR 227 million program completed by June 30 and a new EUR 200 million program launched July 1. Management balances remittances against solvency, maintaining cash at holding near target levels.

We note disciplined use of reinsurance to improve capital efficiency and reduce earnings volatility. Dilution from SBC is modest relative to buybacks, with a portion of repurchased shares earmarked to offset plans. Track record since 2020 supports a high score.

CEO Lard Friese has led a multi-year simplification and de-risking strategy, met or exceeded 2025 targets, and is steering the move to a U.S.-centered group. Will Fuller’s appointment as President and COO effective January 1, 2027, consolidates oversight of Transamerica, International, and Aegon AM.

Governance is being modernized with a U.S.-aligned framework and a new agreement with Vereniging Aegon to simplify the capital structure and align voting with economic ownership. Strategy and communication are clear, though execution risk remains around the UK sale closing, redomiciliation, and achieving durable growth in the U.S. middle market.